Patent · US Active

Methods of administering IgG1 antibodies and methods of suppressing angiogenesis

US10562974B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2014
Grant dateFeb 18, 2020
Priority date—
Expiry dateFeb 9, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of suppressing angiogenesis involves administering to a subject an isolated Fc fragment of an IgG1 antibody, or an IgG1 antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.